HERAMED LIMITED

Analyst Reco. HeraMED Limited

Equities

HMD

AU0000028367

Delayed Australian S.E. Other stock markets 12:50:07 2024-04-02 am EDT			5-day change	1st Jan Change
0.0175 ^AUD	-12.50%		0.00%	-27.08%

Mar. 13	HeraMED Partners With FemBridge for Maternity Health Service; Shares Jump 15%	MT
Mar. 11	Heramed Limited Announces Board Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HeraMED's Clinical Trial Results for Fetal Heart Rate Monitor Published in Peer-Reviewed Journal	22-11-08	MT
HeraMED Confirms Effectivity of Fetal Heart Rate Monitoring Device	22-07-19	MT
HeraMED Limited Provide an Update on the Trial of Smart Medical Grade Foetal Heart Rate Monitor HeraBEAT, and Cloud Based SaaS Pregnancy Monitoring Platform HeraCARE PRO	19-08-27	CI
Heramed Limited Launches Its Medical Grade Foetal Heart Rate Monitor, HeraBEAT	19-06-18	CI
HeraMED Limited Submits 510K Application to the US Food and Drug Administration to Seek FDA Approval for its Medical Grade, Foetal Heart Rate Monitor, the HeraBEAT	19-04-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer